Infectious Disease CE Activities

RMEI DECISION SUPPORT AIDS

View Details

Navigating Nontuberculous Mycobacteria Lung Disease

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is challenging and often delayed due to non-specific symptoms, indolent disease course, and similarities to tuberculosis and other lung diseases; several barriers to its treatment also persist.
View Details

Diagnostic and Susceptibility Testing for Nontuberculous Mycobacterial Lung Diseases

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is a challenging infection that is becoming increasingly prevalent and continues to be a growing concern.
View Details

Considering Therapies for Influenza Treatment and Post-Exposure in Children

This Decision Support Aid serves as a quick reference to help clinicians apply information to their daily practice and care of patients.

LATEST INFECTIOUS DISEASE ARTICLES

RSS Latest Infectious Disease Articles
  • Second-Line Antiretroviral Therapy for Children Living with HIV in Africa May 15, 2025
    In this clinical trial of second-line antiretroviral therapy in children with HIV in Africa, regimens including tenofovir alafenamide fumarate as the backbone and dolutegravir as the anchor drug were most effective.
    Victor Musiime, Mutsa Bwakura-Dangarembizi, Alexander J. Szubert, Vivian Mumbiro, Hilda A. Mujuru, Cissy M. Kityo, Abbas Lugemwa, Katja Doerholt, Chishala Chabala, Shafic Makumbi, Veronica Mulenga, Helen McIlleron, David Burger, Eva Natukunda, Clare Shakeshaft, Kyomuhendo Jovia Linda, Kusum Nathoo, Lara Monkiewicz, Ibrahim Yawe, Monica Kapasa, Mary Nyathi, Joyce Lungu, Bwendo Nduna, Wedu Ndebele, Annabelle South, Mwate Mwamabazi, Godfrey Musoro, Anna Griffiths, Khozya Zyambo, Rashidah Nazzinda, Kevin Zimba, Yingying Zhang, Simon Walker, Anna Turkova, A. Sarah Walker, Alasdair Bamford, Diana M. Gibb, the CHAPAS-4 Trial Team
  • NEJM Outbreaks Update — H5N1 in Indiana May 15, 2025
    In this NEJM Outbreaks Update, Editor-in-Chief Eric Rubin and Deputy Editor Lindsey Baden are joined by Indiana Commissioner of Public Health Lindsay Weaver to discuss the current state of avian influenza in Indiana.
    Eric J. Rubin, Lindsey R. Baden, Lindsay M. Weaver, Stephen Morrissey
  • Pegivirus-Associated Encephalomyelitis in Immunosuppressed Patients May 8, 2025
    Pegivirus hominis, a common virus that has not been linked to specific diseases, was detected in CSF, serum, and brain tissue from four patients with encephalomyelitis, with evidence of independent replication in the CNS.
    Franziska Scheibe, Julia Melchert, Helena Radbruch, Eberhard Siebert, Till D. Best, Siegfried Kohler, Mira Fitzek, Alexander Kowski, Volker Siffrin, Jenny Meinhardt, Raphael Raspe, Viktor Horst, Bianca Zukunft, Klemens Budde, Frank K.H. van Landeghem, Christopher Power, Kai-Uwe Eckardt, Matthias Endres, Christian Drosten, Victor M. Corman, Klemens Ruprecht

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.